Literature DB >> 19500013

HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.

Christopher P Loo1, Brian R Long, Frederick M Hecht, Douglas F Nixon, Jakob Michaëlsson.   

Abstract

Natural killer (NK) cells can directly recognize virus-infected cells. Here, we demonstrate that NK cells also produce interferon (IFN)-gamma in an HIV-1-specific, T cell-dependent manner. After stimulation of peripheral blood mononuclear cells (PBMCs) from HIV-1-infected individuals with HIV-1-derived peptides, up to half of the IFN-gamma-producing PBMCs are NK cells. These results indicate that T cell-dependent NK cell IFN-gamma production can be important for immune control of HIV-1, and have implications for the interpretation of data from vaccine trials using ELISPOT and ELISA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500013      PMCID: PMC2853859          DOI: 10.1089/aid.2008.0165

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

2.  T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Authors:  Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.

Authors:  Shyam Kottilil; Tae-Wook Chun; Susan Moir; Shuying Liu; Mary McLaughlin; Claire W Hallahan; Frank Maldarelli; Lawrence Corey; Anthony S Fauci
Journal:  J Infect Dis       Date:  2003-03-13       Impact factor: 5.226

4.  Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Authors:  Maureen P Martin; Ying Qi; Xiaojiang Gao; Eriko Yamada; Jeffrey N Martin; Florencia Pereyra; Sara Colombo; Elizabeth E Brown; W Lesley Shupert; John Phair; James J Goedert; Susan Buchbinder; Gregory D Kirk; Amalio Telenti; Mark Connors; Stephen J O'Brien; Bruce D Walker; Peter Parham; Steven G Deeks; Daniel W McVicar; Mary Carrington
Journal:  Nat Genet       Date:  2007-05-13       Impact factor: 38.330

5.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

6.  Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.

Authors:  T A Fehniger; G Herbein; H Yu; M I Para; Z P Bernstein; W A O'Brien; M A Caligiuri
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

Review 7.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

8.  Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.

Authors:  Galit Alter; Maureen P Martin; Nickolas Teigen; William H Carr; Todd J Suscovich; Arne Schneidewind; Hendrik Streeck; Michael Waring; Angela Meier; Christian Brander; Jeffrey D Lifson; Todd M Allen; Mary Carrington; Marcus Altfeld
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

  8 in total
  2 in total

1.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

2.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.